On March 2, 2025, the Nevada State Legislature introduced Assembly Bill 170, a significant piece of legislation aimed at expanding the prescribing authority of associate osteopathic physicians. This bill seeks to address the growing demand for healthcare providers in the state, particularly in underserved areas, by allowing these practitioners to prescribe controlled substances under specific conditions.

The primary provisions of AB170 enable associate osteopathic physicians to prescribe controlled substances listed in schedules III, IV, and V, as well as certain schedule II substances containing hydrocodone. However, the bill imposes restrictions on the quantity of prescriptions, limiting them to a maximum of a five-day supply for most controlled substances, while allowing a 30-day supply of buprenorphine for treating substance use disorders under supervision.

A notable aspect of the bill is the requirement for associate osteopathic physicians to operate under a collaborative practice agreement with a supervising osteopathic physician, who must be physically present during the prescription process. This provision aims to ensure patient safety while expanding access to care.

The introduction of AB170 has sparked discussions among healthcare professionals and lawmakers. Proponents argue that the bill will alleviate the burden on primary care providers and improve access to necessary medications, particularly in rural areas where healthcare resources are limited. Critics, however, express concerns about the potential for over-prescription and the adequacy of training for associate osteopathic physicians in managing controlled substances.

Economically, the bill could have significant implications for Nevada's healthcare system. By increasing the number of qualified prescribers, it may reduce wait times for patients and enhance the overall efficiency of healthcare delivery. Socially, the legislation could play a role in addressing the opioid crisis by facilitating access to treatment options for substance use disorders.

As AB170 moves through the legislative process, its potential impact on healthcare access and patient safety will be closely monitored. Stakeholders are encouraged to engage in discussions about the bill's provisions and their implications for the future of healthcare in Nevada. The outcome of this legislation could set a precedent for similar measures in other states, highlighting the ongoing evolution of healthcare practices in response to changing needs.